دكتوراهExpired

Modeling the Mechanism of Action of DNA Intercalators for Cancer Therapy Applications (M/F)

EURAXESS hosting organisation · عدة بلدان أوروبية

Traditional anticancer chemotherapy often lacks spatial and temporal precision, leading to unintended damage to healthy tissues. An innovative alternative involves developing light-activated molecules whose cytotoxicity is triggered only upon exposure to visible or infrared light, enabling targeted, controlled therapy. This approach enhances efficacy while minimizing off-target effects. Building on promising preliminary results (including a patent filing), we have designed novel molecules that become active upon irradiation. However, their mechanisms of activation (which depend critically on molecular substituents) remain incompletely understood. Additionally, predicting how these activated molecules interact with DNA is essential for optimizing their therapeutic potential. The person sele

At a glance

Where: Multiple European countries
Deadline: 2026-09-23
Funding: Funding described on programme page
Board: EURAXESS

Who can apply

Criteria stated by the funder on the official source.

Nationality

EURAXESS vacancies rarely print a nationality table. Confirm whether applicants from Tunisia can apply and whether a residence/work permit pathway exists on the employer page.

غير مذكور

Education

Research Field Chemistry Education Level PhD or equivalent Research Field Chemistry Education Level PhD or equivalent Languages FRENCH Level Basic Research Field Chemistry Years of Research Experience 1 - 4 Research Field Chemistry » Computational chemistry Years of Research Experience 1 - 4

غير مذكور

Funding and what it does not cover

Funding details were taken from the official programme page text. Confirm the current call before applying.